Antibodies… What Are The Alternatives?
The recent growth of the antibody therapeutics market has led to a great deal of investment in this field. Over the last 20 years a number of alternatives to antibodies, displaying similar properties but with functional advantages, have been developed...
|
See You Next Year at Pivotal Links 2020!
This year was our biggest and best event to date! With 72 companies and a grand total of 114 people attending this year, it is easy to see why Pivotal Links is the biggest networking event in the research reagent calendar. Plans for Pivotal Links 2020 are already well underway!
|
RD-Biotech becomes supplier of clones D1.25 and 1112-1 for the quantification of the rabies virus by ELISA!
(Anti-rabies virus monoclonal antibodies) Signature of a license agreements with the Wistar Institute – USA (clone 1112.1) and with Institut Pasteur – France (clone D1.25). This allows for the commercialisation of the antibody pair for the detection of the rabies virus glycoprotein G by ELISA: - Monoclonal antibody 1112-1: Capture antibody
- Monoclonal antibody D1-25: Detection antibody, biotinylated
Business Development – Reflecting on Pivotal Links 2019
Commercialising your company: Pivotal Links 2019 confirmed the trend of greater Research & Development Vs Sales and Marketing. "As the Business Development Manager for Pivotal Scientific Limited, it was interesting to host and participate in meetings, and equally insightful to observe how individuals interact with one another in such a conference setting..."
|
As loyal members of the PSL Alliance, we would like to reward you for suggesting companies to join our family of PSL Alliance members. Should your suggested company sign up, you'll receive a 25% discount on your next renewal!
|
Pivotal Scientific are on the road, meet us this Summer!
AACC – 6th – 8th August 2019 Anaheim, USA Richard Atkins – Commercial Director - Board Member
|
IVIS – 13th – 16th August 2019 Seattle, USA Tim Bernard – CEO
|
|